PPARA and fatty liver disease: Among phthalates, the di-ethyl-hexyl-phthalate (DEHP) exerts its obesogenic action up-regulating hepatic pparα, cb1, and srebp levels and stimulating de novo FA synthesis and hepatic steatosis.